David Annis
Chief Tech/Sci/R&D Officer chez AILERON THERAPEUTICS, INC.
Fortune : 2 500 $ au 31/03/2024
Profil
David Allen Annis is currently the Senior Vice President-Research at Aileron Therapeutics, Inc. He previously worked as the Director-Technology Development at Schering-Plough Research Institute and as the Vice President-New Technologies at NeoGenesis Pharmaceuticals, Inc. Dr. Annis received his graduate and doctorate degrees from Harvard University and his undergraduate degree from Georgia Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/11/2023 | 377 ( 0,01% ) | 2 500 $ | 31/03/2024 |
Postes actifs de David Annis
| Sociétés | Poste | Début |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/11/2018 |
Anciens postes connus de David Annis
| Sociétés | Poste | Fin |
|---|---|---|
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Corporate Officer/Principal | - |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Formation de David Annis
| Harvard University | Doctorate Degree |
| Georgia Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
